Treating hepatitis C: a clinician's perspective. Interview by Bob Roehr.
Powell
J
J
D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy / Q000009:adverse effects; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections / Q000150:complications; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D016031:Liver Transplantation; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin